EUVIMEDEUVIMED entdecken
Open Access

Effect of Hemodiafiltration and Hemodialysis on Postoperative Mortality in Patients With Kidney Failure

Dharmenaan Palamuthusingam, Carmel M Hawley, Elaine M Pascoe, David Wayne Johnson, Martin Wolley, Stephen McDonald, Neil Boudville, Matthew D Jose, Girish Talaulikar iD, Nicholas B Cross, Magid Fahim

Hemodialysis International · 2026

DOI: 10.1111/hdi.70072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hemodialysis International, 2026. Verfasst von Dharmenaan Palamuthusingam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Metro North Kidney Health Service, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia. Hauptthemen laut MEDLINE: Hemodiafiltration, Renal Dialysis, Postoperative Complications, Kidney Failure, Chronic. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Royal Australasian College of Physicians.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Patients receiving chronic dialysis have increased risks of postoperative mortality and morbidity. Studies have suggested that patients receving hemodiafiltration (HDF) compared to hemodialysis (HD) may benefit from improved cardiovascular health, reduced infections and better overall survival. This study aimed to determine if patients receving HDF had improved postoperative outcomes after elective surgery compared to patients receiving HD.

Methods

Bi‐national population cohort study evaluated all incident and prevalent patients receiving chronic hemodialysis in Australia and New Zealand. Surgeries included upper gastrointestinal, anorectal, hernia surgery, cholecystectomy and appendectomy. The primary outcome was 30‐day all‐cause mortality. Secondary outcomes included cardiovascular and infective outcomes. As there was potential for data to be correlated with multiple surgeries clustered at the patient and centre level, a multi‐level mixed effects logistic regression model was used, with patient level covariates as fixed effects and dialysis centre as random intercepts, whereby patients were nested within centres.

Results

During the study period, there were 1750 surgeries in 1669 patients, of which 416 (23.8%) were receiving HDF. The median age was similar in both groups, as was the prevalence of comorbidities. Patients receiving HDF had received dialysis for a shorter period (0.9 vs. 2.3 years, p < 0.001). The 30‐day mortality rate was lower in patients receiving HDF than in those receiving HD (1.9 vs. 3.3%, p < 0.005). Using multi‐level mixed effects logistic regression, HDF was not associated with reduced mortality odds (OR 0.84, 95% CI 0.37–1.93) compared to patients receiving HD. Patients on HDF experienced a lower rate of a composite of infections (5.5 vs. 9.8%, p = 0.012), and required less blood transfusions (7.7 vs. 12.4%, p = 0.009). The occurrence of cardiovascular complications was not significantly different between the two groups (1.4 vs. 2.3%, p = 0.280).

Conclusions

The use of HDF was not associated with lower postoperative mortality odds but lower rates of infective complications compared to HD were observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemodiafiltrationRenal DialysisPostoperative ComplicationsKidney Failure, ChronicHumansFemaleMaleMiddle AgedAgedNew ZealandAustraliaCohort Studies

Stichwörter der Autor:innen

abdominal surgerycardiovascularchronic dialysisgeneral surgeryhemodiafiltrationhemodialysisinfectionkidney failurepostoperative mortality

Autor:innen und Institutionen

  • Metro North Kidney Health Service, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Faculty of Medicine, University of Queensland, St Lucia, Queensland, Australia.
  • School of Medicine, Griffith University, Southport, Queensland, Australia.
  • Metro South Kidney and Transplant Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
  • Australasian Kidney Trials Network (AKTN), University of Queensland, Brisbane, Australia.
  • Centre for Health Services Research, University of Queensland, St Lucia, Queensland, Australia.

ORCID-Profile: Girish Talaulikar

Förderung

  • Royal Australasian College of Physicians

Zitieren

APA

Palamuthusingam, D., Hawley, C. M., Pascoe, E. M., Johnson, D. W., Wolley, M., McDonald, S., Boudville, N., Jose, M. D., Talaulikar, G., Cross, N. B., & Fahim, M. (2026). Effect of Hemodiafiltration and Hemodialysis on Postoperative Mortality in Patients With Kidney Failure. Hemodialysis International. https://doi.org/10.1111/hdi.70072

Vancouver

Palamuthusingam D, Hawley CM, Pascoe EM, Johnson DW, Wolley M, McDonald S, et al. Effect of Hemodiafiltration and Hemodialysis on Postoperative Mortality in Patients With Kidney Failure. Hemodialysis International. 2026. doi:10.1111/hdi.70072

BibTeX
@article{Palamuthusingam2026,
  author = {Palamuthusingam, Dharmenaan and Hawley, Carmel M and Pascoe, Elaine M and Johnson, David Wayne and Wolley, Martin and McDonald, Stephen and Boudville, Neil and Jose, Matthew D and Talaulikar, Girish and Cross, Nicholas B and Fahim, Magid},
  title = {Effect of Hemodiafiltration and Hemodialysis on Postoperative Mortality in Patients With Kidney Failure},
  journal = {Hemodialysis International},
  year = {2026},
  doi = {10.1111/hdi.70072}
}
Kostenlos starten →